Psychemedics Profit Margin 2010-2024 | PMD

Current and historical gross margin, operating margin and net profit margin for Psychemedics (PMD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Psychemedics net profit margin as of December 31, 2024 is -9.26%.
Psychemedics Annual Profit Margins
Psychemedics Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.000B $0.020B
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.987B 19.70
Encompass Health (EHC) United States $12.114B 25.68
DaVita (DVA) United States $10.370B 14.58
Chemed (CHE) United States $8.164B 25.66
Elanco Animal Health (ELAN) United States $7.037B 15.07
Option Care Health (OPCH) United States $5.219B 23.26
RadNet (RDNT) United States $4.245B 269.43
Amedisys (AMED) United States $3.191B 21.46
LifeStance Health (LFST) United States $2.108B 0.00
Addus HomeCare (ADUS) United States $2.098B 23.04
Astrana Health (ASTH) United States $1.477B 36.60
U.S Physical Therapy (USPH) United States $1.187B 30.64
Aveanna Healthcare Holdings (AVAH) United States $0.991B 56.44
Pennant (PNTG) United States $0.956B 35.11
Atai Life Sciences (ATAI) Germany $0.437B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.047B 0.00
Daxor (DXR) United States $0.043B 0.00
Ontrak (OTRK) United States $0.006B 0.00